Pain Management

A preemptive pain management program involving OTC medications can help reduce the need for opioid prescriptions following certain surgeries.

The FDA Committees voted against recommending approval of Nektar Therapeutics' oxycodegol.

The opioid crisis continues to be one of the worst public health crises that the United States has ever seen.

A study evaluated the ability of untrained individuals to use different forms of naloxone administration.

In a new lawsuit, CVS, Walgreen, Rite Aid, and other major pharmacy chains said that they are not to blame in federal opioid litigation

Practical tips to help keep patients safe.

A new study shows increases in the misuse of non-opioid medications among US adults coinciding with decreases in opioid prescribing.

What the law says about pharmacists’ role in the opioid crisis-and how to protect yourself.

Evidence-based framework is an urgent need, study says.

Strategies include nonpharmacologic therapies, nonopioid medications, and opioid rotation. 

Practical tips to help keep patients safe.

New and old non-opioid pain management solutions. 

Patients at-risk for substance abuse more easily identified and managed.

The DEA had access to information about where opioids were being sold, but didn’t act on it. Why?

“Historic investment” distributed to private companies, universities, and researchers.

Controlled substance tramadol among the illegally marketed painkillers.

Approved forms should be considered as options for community distribution.

Fentanyl, oxymorphone, and hydrocodone face greatest cuts.

Texas pharmacies worked with “runners” to divert prescription opioids to the streets.

Grant-funded program to bring more opportunities for safe disposal.

Pharmacists must continue to minimize the convenience gap between physician and pharmacy.

76 billion opioid pain pills distributed from 2012-2016.

Prosecutors are bringing accountability to the opioid epidemic.

Results from new ASHP Survey.

Patient data provides a rich resource that can help address the problem of opioid misuse and addiction among their health plan members.

Virus-like particle research could lead to a vaccine against opioid addiction.

Organization calls for state-level legislative and regulatory revisions.

Results of a recent survey suggest employee-based drug abuse is a concern for many healthcare providers, though they don’t believe it can happen in their facilities.

The action by the U.S. Attorney's Office is the latest in legal and policy maneuvers aimed at ending the opioid epidemic.

Results from IQVIA Institute for Human Data Science's annual report, "Medicine Use and Spending in the U.S."